Clinical Trial Update: Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase II trial evaluating TQB3616 capsules for recurrent/metastatic breast cancer. The study status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TQB3616 capsules (TQB3616)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING